Miriam Wittmann
- T Helper 2 IL-4/IL-13 Dual Blockade with Dupilumab Is Linked to Some Emergent T Helper 17‒Type Diseases, Including Seronegative Arthritis and Enthesitis/Enthesopathy, but Not to Humoral Autoimmune Diseases
2022/04/05 by Charlie Bridgewood, Miriam Wittmann, Tom Macleod +9 · 28 citations
Immunology and Microbiology · Medicine · #IL-33, ST2, and ILC Pathways #Urticaria and Related Conditions #Psoriasis: Treatment and Pathogenesis